| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Oct 17, 2024 | Upstream Bio, Inc. | 10% Owner | Buy | 100.0 | +1,175,000 | 100.00% | ✗ | $20M |
| Aug 15, 2022 | Aug 17, 2022 | Verona Pharma plc | 10% Owner | Buy | 96.3 | +4,800,000 | 9.39% | ✗ | $6.3M |